Literature DB >> 10100586

Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5).

P Coppo1, J P Laporte, M Aoudjhane, P Lebon, F Isnard, S Lesage, N C Gorin, A Najman.   

Abstract

Progressive multifocal leucoencephalopathy is an opportunistic JC virus-related pathology occurring in immunocompromised patients. We report a case of severe cellular immunodeficiency in a patient who underwent autologous bone marrow transplantation for acute myeloblastic leukemia, and who subsequently developed progressive multifocal leucoencephalopathy, an unusual pathology in this context. Progressive multifocal leucoencephalopathy was preceded by a peripheral demyelinating neuropathy. We discuss the possible link between these two neuropathies, the possible aggravation or activation from CMV infection, as well as the possible contribution of bone marrow purging in the resultant cellular immunodeficiency.

Entities:  

Mesh:

Year:  1999        PMID: 10100586     DOI: 10.1038/sj.bmt.1701555

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  11 in total

1.  JC Virus Infection After Transplantation: Beyond the Classic Progressive Multifocal Leukoencephalopathy?

Authors:  Supha Kijpittayarit; Raymund R Razonable
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-01

2.  Progressive multifocal leukoencephalopathy with peripheral demyelinating neuropathy in a liver transplant patient.

Authors:  Smruti R Mohanty; Giuliano Testa; Douglas R Labrecque; Frank A Mitros
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-01

3.  Progressive multifocal leukoencephalopathy in transplant recipients.

Authors:  Farrah J Mateen; RajaNandini Muralidharan; Marco Carone; Diederik van de Beek; Daniel M Harrison; Allen J Aksamit; Mary S Gould; David B Clifford; Avindra Nath
Journal:  Ann Neurol       Date:  2011-08       Impact factor: 10.422

Review 4.  Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.

Authors:  Leslie J Marshall; Eugene O Major
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-17       Impact factor: 4.147

5.  Bone marrow-derived mesenchymal stem cells undergo JCV T-antigen mediated transformation and generate tumors with neuroectodermal characteristics.

Authors:  Luis Del Valle; Sergio Piña-Oviedo; Georgina Perez-Liz; Brian J Augelli; S Ausim Azizi; Kamel Khalili; Jennifer Gordon; Barbara Krynska
Journal:  Cancer Biol Ther       Date:  2010-02-01       Impact factor: 4.742

6.  Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy.

Authors:  Angela Marzocchetti; Christian Wuthrich; Chen S Tan; Troy Tompkins; Francisco Bernal-Cano; Parul Bhargava; Allan H Ropper; Igor J Koralnik
Journal:  J Neurovirol       Date:  2008-11-06       Impact factor: 2.643

7.  Detection and typing of BKV, JCV, and SV40 by multiplex nested polymerase chain reaction.

Authors:  Massimiliano Bergallo; Cristina Costa; Samuela Margio; Francesca Sidoti; Giuseppe P Segoloni; Alessandro Negro Ponzi; Rossana Cavallo
Journal:  Mol Biotechnol       Date:  2007-03       Impact factor: 2.695

8.  Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation.

Authors:  Chen S Tan; Bruce J Dezube; Parul Bhargava; Patrick Autissier; Christian Wüthrich; Janice Miller; Igor J Koralnik
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

9.  Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study.

Authors:  O Fernández; C Oreja-Guevara; R Arroyo; G Izquierdo; J L Pérez; X Montalban
Journal:  J Neurol       Date:  2012-09       Impact factor: 4.849

10.  Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

Authors:  Roderick P P W M Maas; Annemarie H G Muller-Hansma; Rianne A J Esselink; Jean-Luc Murk; Clemens Warnke; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.